With the AI solution for radiology, Prostate.Carcinoma.ai, FUSE-AI has been awarded in the "Health AI" category! The „KI Innovation Award“ recognizes outstanding achievements in the development and implementation of artificial intelligence technologies. Founded in 2019, FUSE-AI is known for its innovative medical AI software that supports radiological practice.

With our AI solution “Prostate.Carcinoma.ai”, we have reached the final round of two prestigious competitions: the AI Innovation 2024 and the KPMG Venture Champion Award. The AI Innovation Award, presented by the AI Federal Association Germany, recognizes pioneering achievements of companies. The focus is not only on the development of the company's own AI solution but also on its sustainable impact on the industry and society overall.

At the congress 'Anonymization for Secure Data Usage', leading branches heads came together in Lübeck from April 16th to 17th, 2024, to present and discuss the latest findings and innovative approaches to data anonymization.

Radiology clinics and practices in Switzerland can now obtain the AI-based software "Prostate.Carcinoma.ai" from the Hamburg-based e-health company FUSE-AI centrally through T-Systems, which assists radiologists in analyzing prostate MR images.

We're thrilled to have experienced such a great turnout and interest at the ECR in Vienna last week! Once again, it's been confirmed that we're on the right track. Our major advantage is that we offer "Prostate.Carcinoma.ai" to our customers as fully integratable software.

Our AI-based software Prostate.Carcinoma.ai supports radiologists in the detection and segmentation of the prostate gland, their zones and suspicious lesions on MRI images. Mint Medical was involved in our software development from the very beginning with advice and their experiences as platform developer for radiologists.

Arab Health 2024 is the largest trade fair and congress for medicine and healthcare in the Middle East that ran from January 29 - February 1 this year.

On December 15, we were very happy to receive the announcement from our Notified Body that we have fulfilled all the requirements of EU MDR IIa.

Next week, November 13-16, MEDICA, one of the largest B2B medical trade fairs worldwide, will open its doors in Düsseldorf, Germany. FUSE-AI will be presenting its AI-based software Prostate.Carcinoma.ai and other AI-based software solutions for use in diagnostics in Hall 12/A36. As part of the Xlife Sciences network, we exhibit together with three partner companies of Xlife Sciences AG, Switzerland.